← Evidence map

ReviewDrugs2012

Dapagliflozin: a review of its use in type 2 diabetes mellitus.

Greg L PloskerPubMed ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

2 trials

NCT02925559phase 4135 enrolled2016NCT02211742phase 412 enrolled2014
Full record →Abstract, authors, funding and every citing paper · PMID 23170914